24624849|t|[Dexmedetomidine use for intravenous sedation and delirium treatment during early postoperative period in cardio-surgical patients].
24624849|a|OBJECTIVE OF THE STUDY: to analyze the efficiency and safety of Dexmedetomidine infusion for a short-term controlled sedation and treatment of delirium in the early postoperative period in patients after cardiac surgery. METHODS: open, randomized, prospective study of 28 patients undergoing surgery on the heart or main blood vessels under general anaesthesia. In the early postoperative period all patients received an infusion of Dexmedetomidine (0.2-1.4 microg kg(-1) per hour) for sedation. The analgesia was carried out with Ketoprofen according to the protocol and Trimeperidine if VAS was > or = 3. Sedation and agitation levels were measured by Ramsay and RAAS scales, speed of awaking by Aldrete score. Duration of mechanical ventilation, length of stay in ICU, need for analgesics (VAS scale), type and frequency of side effects and vital signs (Harward standart) were recorded. Type of delirium, time of onset (days after surgery), dose and duration of psychomotor agitation were evaluated in patients with delirium (n = 9). RESULTS: Dexmedetomidine infusion in the medium therapeutic doses resulted mild or moderate sedation remaining up to 12 hours after the infusion. More than 50% of patients had retrograde amnesia. The pain intensity did not exceed 1 point on VAS scale in 96% of patients. 23% of patients required an additional administration of Trimeperidine. The most common side effects were bradycardia (39%) and arterial hypotension (36%). The therapy with Dexmedetomidine provided the most optimal level of sedation compared to other combinations of drugs (haloperidol, midazolam, propofol) in patients with delirium according to sedation-agitation and awaking scales. CONCLUSIONS: Dexmedetomidine provides dose-dependent sedation and retrograde amnesia without altering the verbal contact, does not cause respiratory depression. The drug has independent analgesic effect and proved to be effective in the treatment of delirium. The most frequent side effects of Dexmedetomidine are bradycardia and arterial hypotension.
24624849	1	16	Dexmedetomidine	Chemical	MESH:D020927
24624849	50	58	delirium	Disease	MESH:D003693
24624849	122	130	patients	Species	9606
24624849	197	212	Dexmedetomidine	Chemical	MESH:D020927
24624849	276	284	delirium	Disease	MESH:D003693
24624849	322	330	patients	Species	9606
24624849	405	413	patients	Species	9606
24624849	533	541	patients	Species	9606
24624849	566	581	Dexmedetomidine	Chemical	MESH:D020927
24624849	664	674	Ketoprofen	Chemical	MESH:D007660
24624849	705	718	Trimeperidine	Chemical	MESH:D011396
24624849	753	762	agitation	Disease	MESH:D011595
24624849	1031	1039	delirium	Disease	MESH:D003693
24624849	1098	1119	psychomotor agitation	Disease	MESH:D011595
24624849	1138	1146	patients	Species	9606
24624849	1152	1160	delirium	Disease	MESH:D003693
24624849	1179	1194	Dexmedetomidine	Chemical	MESH:D020927
24624849	1333	1341	patients	Species	9606
24624849	1346	1364	retrograde amnesia	Disease	MESH:D000648
24624849	1370	1374	pain	Disease	MESH:D010146
24624849	1431	1439	patients	Species	9606
24624849	1448	1456	patients	Species	9606
24624849	1498	1511	Trimeperidine	Chemical	MESH:D011396
24624849	1547	1558	bradycardia	Disease	MESH:D001919
24624849	1569	1589	arterial hypotension	Disease	MESH:D007022
24624849	1614	1629	Dexmedetomidine	Chemical	MESH:D020927
24624849	1715	1726	haloperidol	Chemical	MESH:D006220
24624849	1728	1737	midazolam	Chemical	MESH:D008874
24624849	1739	1747	propofol	Chemical	MESH:D015742
24624849	1752	1760	patients	Species	9606
24624849	1766	1774	delirium	Disease	MESH:D003693
24624849	1797	1806	agitation	Disease	MESH:D011595
24624849	1840	1855	Dexmedetomidine	Chemical	MESH:D020927
24624849	1893	1911	retrograde amnesia	Disease	MESH:D000648
24624849	1964	1986	respiratory depression	Disease	MESH:D012131
24624849	2077	2085	delirium	Disease	MESH:D003693
24624849	2121	2136	Dexmedetomidine	Chemical	MESH:D020927
24624849	2141	2152	bradycardia	Disease	MESH:D001919
24624849	2157	2177	arterial hypotension	Disease	MESH:D007022
24624849	Negative_Correlation	MESH:D006220	MESH:D003693
24624849	Positive_Correlation	MESH:D020927	MESH:D000648
24624849	Positive_Correlation	MESH:D020927	MESH:D001919
24624849	Negative_Correlation	MESH:D020927	MESH:D003693
24624849	Positive_Correlation	MESH:D020927	MESH:D007022

